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Background: Recent meta-analyses of primary prevention trials have suggested that women may not have the same mortality benefit from an 
implantable cardioverter-defibrillator (ICD) and may receive less ICD therapy post implantation as compared to men. However, there is limited 
information regarding outcomes by gender in a general ICD population.
Methods: We identified 1445 patients of which 322 were women, who underwent ICD implantation at a tertiary care center for current clinical 
indications. Using a propensity matched cohort design, we identified 291 women who could be matched to men, based on age, indication, etiology 
of cardiomyopathy and type of device. All cause mortality and appropriate ICD therapy were measured as end points using multivariable cox 
regression analysis.
Results: The total cohort of 582 patients had an average age of 65±13 years, ejection fraction of 28±14 with a mean follow up of 909±901 
days. There was no difference in the total mortality of 25% in both men and women (p=0.96), nor in time to death 955±941 vs. 878±848 
days respectively (p=0.15). In addition, there was no mortality difference identified by subgroup analysis (Figure 1). Women with non-ischemic 
cardiomyopathy (NICM) were less likely to receive appropriate ICD therapy AHR 0.8 (95% CI 0.62-0.95) p= 0.03.
Conclusions: In a general ICD population there is no gender difference in mortality across all subgroups. However, women with NICM have a lower 
incidence of appropriate ICD therapy.
 
